HDAC3 and colitis: In summary, our study revealed that HDAC3 is upregulated in the colonic mucosa during the development of DSS-induced colitis, and that inhibition of HDAC3 with RGFP966 via intraperitoneal injection and conditional knockout of HDAC3 in CX3CR1-positive monocytes could attenuate DSS-induced tissue damage.